Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Applied Dna Scns (APDN)

Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Applied DNA Sciences: Fiscal Q3 Earnings Snapshot AP - Thu Aug 8, 3:24PM CDT

Applied DNA Sciences: Fiscal Q3 Earnings Snapshot

APDN : 0.3390 (-9.60%)
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics ACCESSWIRE - Thu Jun 20, 4:15AM CDT

- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability -- Applied DNA Secures Commercial Linea RNAP Quantity Sufficient...

APDN : 0.3390 (-9.60%)
MRVI : 7.88 (-7.29%)
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics ACCESSWIRE - Thu Jun 20, 4:15AM CDT

- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability -- Applied DNA Secures Commercial Linea RNAP Quantity Sufficient...

APDN : 0.3390 (-9.60%)
MRVI : 7.88 (-7.29%)
Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML ACCESSWIRE - Mon May 13, 3:55AM CDT

STONY BROOK, NY / ACCESSWIRE / May 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, and the Institute of Hematology and Blood Transfusion (ÚHKT/IHBT)...

APDN : 0.3390 (-9.60%)
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot AP - Fri May 10, 3:13PM CDT

Applied DNA Sciences: Fiscal Q2 Earnings Snapshot

APDN : 0.3390 (-9.60%)
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results ACCESSWIRE - Fri May 10, 11:05AM CDT

STONY BROOK, NY / ACCESSWIRE / May 10, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced consolidated financial results...

APDN : 0.3390 (-9.60%)
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot AP - Thu Feb 8, 3:40PM CST

Applied DNA Sciences: Fiscal Q1 Earnings Snapshot

APDN : 0.3390 (-9.60%)
Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow ACCESSWIRE - Thu Dec 14, 2023

- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times -

APDN : 0.3390 (-9.60%)
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot AP - Thu Dec 7, 2023

Applied DNA Sciences: Fiscal Q4 Earnings Snapshot

APDN : 0.3390 (-9.60%)
Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results ACCESSWIRE - Thu Dec 7, 2023

- Conference Call/Webcast Scheduled for Today at 4:30 PM ET -

APDN : 0.3390 (-9.60%)

Barchart Exclusives

2 Dividend Aristocrats to Buy Hand Over Fist as Markets Price in a Trump Presidency Barchart - Tue Oct 22, 6:30PM CDT
Some analysts believe that stock markets are pricing a Trump victory in the upcoming U.S. presidential elections. Nucor and ExxonMobil look like two Dividend Aristocrats to buy for investors looking to bet on a second Trump presidency. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot